chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Small rash on hind that itched for a couple of hours. Once it stopped itching the rash turned in to what looked like a burn mark and the skin starting tearing and bleeding. I?ve been wearing a bandaid and I still have the mark today (1 week later), although it is slowly going away.
Patient describes redness, swelling and warmth. Also said the redness is moving across arm.
Extreme chills, achy muscles, dizziness, and fast heartbeat. Injection site is swollen and painful.
Fever; Chills; Pain in arms; Stomach ache; Stuffy nose; This is a spontaneous report from a non-contactable consumer, the patient.  A 20-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration on 05May2021 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported.  Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On an unknown date in 2021, the patient experienced fever, chills, pain in arms, stomach ache and stuffy nose. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, pain in arms, stomach ache and stuffy nose was resolved on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Pt given Hepatitis B vaccine #1 Lot #1208M exp 4/11/05, also given Montoux PPD Lot #C1114A exp 9/14/04. Pt left office to parking lot, had fainting episode. Brought back to office. Blood pressure and pulse taken, BP 62, systolic pulse 60. After ammonia inhalant administered by MD, BP fallen again 112/68 and pulse 72. 911 called. Pt taken for evaluation. Probably not related vasovagal episode - to hepatitis or vax.
My symptoms were like a very bad cold.  The outcome is that symptoms resolved after three or four days.
This case was reported by a other health professional via sales rep and described the occurrence of shingles in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional information was received as follows: The case was reported by the pharma manager. The age group was not reported but was selected as adult as per vaccine indication. The patient developed shingles between the 1st and the 2nd dose of SHINGRIX. The GlaxoSmithKline account manager called into MI and stated that the pharmacy manager reported a SHINGRIX adverse event with a question to one of her colleagues.
12 year old patient received 5-11 pediatric vaccine for the second dose.  Patient was 11 years old when she got the first dose. No adverse reactions noted.
Rt arm (back) SQ injection redden, swollen 12 cm. seen on 6-20-19. Reffered for medical at 11:30 AM on 6-20-19 She was Dx with cellulitis and Rx with cephalexin 250mg/4 x's daily / one wk
Patient received Fluarix vaccine, which is not approved for children under age 18.  No apparent side effects according to mom.
w/in 24hr of vax pt devel weakness (gen), myalgia & confusion;pt was adm to hosp;pt seen by neurologist;CSR, LP, head CT & several MRI reported;pt had lt wandering eye dx ptosis;pt ? encephalitis vs acute demyelination;poss MS or GBS;
Complained of severe shortness of breath and chills night of vaccination; no treatment saught; resolved by 1/21/2020 with no intervention
Pt got up after 15 minutes and felt sick-reported nausea and feeling hot.  Gave water and called rapid response, no other intervention.
DVT w/PE 13 days post vaccination.  Two day admission to hospital.  Treatment of Eluiquis ongoing.
CHEST TIGHTNESS, CHEST PAIN, DYSPNEA, MYALGIA BEGINNING 48 HRS AFTER VACCINE WAS GIVEN, LASTING > 48 HOURS. GRADUAL DISSIPATION IS NOTED.
ERYTHEMATOUS PAPULAR RASH WITH EXCORIATION ON THE LEFT UPPER AND LOWER LIMB.
Extreme pain in my right knee and thigh/extreme pain my left ankle and calve; Extreme pain in my right knee and thigh/extreme pain my left ankle and calve; This is a spontaneous report from a contactable consumer (patient). A 58-years-old male patient received bnt162b2 (PFIZER COVID 19 VACCINE, Solution for injection, Lot Number: ER2613), via an unspecified route of administration, administered in arm right on 21Mar2021 13:00 (at the age of 58-years-old) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Known allergies was none. Prior to vaccination, the patient had not detected with Covid. Post vaccination, the patient had not tested Covid. No other vaccine in four weeks. Concomitant medications included ticagrelor (BRILINTA); naproxen (MANUFACTURER UNKNOWN); boswellia serrata/resin/colecalciferol/collagen (OSTEO BI-FLEX); ascorbic acid (VIT C); vitamin d3 (MANUFACTURER UNKNOWN); vitamin b complex (B COMPLEX); acetylsalicylic acid (LOW DOSE ASPIRIN); atorvastatin calcium (LIPITOR), all for an unspecified indication, start and stop date were not reported. The patient experienced extreme pain in my right knee and thigh. Got the second shot on 04Mar2021 and 2 days later developed extreme pain my left ankle and calve on 24Mar2021. Pain has not left yet. Had prednisone twice, methyl prednosolone, diclofenac sodium tablets, tramadol again. The pain has not gone away yet. The orthopaedist said something was keeping his tendon inflamed. Bear in mind she had no pain anywhere prior to getting the first shot. The adverse event resulted in doctor or other healthcare professional office or clinic visit. The patient received treatment as prednisone and tramadol for adverse event. Therapeutic measures were taken as a result of events. The outcome of event resolved with sequel on 2021.
Patient said he experienced itching but no pain at the injection site later that morning after receiving the vaccination. His arm became inflamed and slightly pustular. He indicates that the itching dissipated but the redness and raised inflamed area has persisted. He indicated he had tried using a prescription corticosteroid as well as OTC betadine with no resolution of inflammation.
Very sore left arm - difficult movement; Very sore left arm - difficult movement; Sore joints; Achy muscles; fever; chills; anxiety; insomnia; malaise; mild nausea; dizziness; headache; This is a spontaneous report from a contactable consumer (patient). A 44-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EN6200, Expiration Date: not reported), via an unspecified route of administration in left arm on 27Feb2021 07:30 as dose 2, single for COVID-19 immunization (at the age of 44-year-old). Medical history included hypertension, anxiety, other managed conditions and allergies to erythromycin. Patient did not receive other vaccine in four weeks. Patient had numerous prescriptions in two weeks. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EM9809, Expiration Date: not reported), via an unspecified route of administration in left arm on 06Feb2021 11:30 as dose 1, single for COVID-19 immunization. Patient had no covid prior vaccination and was not covid tested post vaccination. The patient experienced very sore left arm - difficult movement, sore joints, achy muscles, fever, chills, anxiety, insomnia, malaise, mild nausea, dizziness, headache on 27Feb2021 14:00. All symptoms began to resolve and decrease after 24 hours, though, some muscle aches and headache mildly remain. The patient did not receive treatment for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Pt states she got home that evening and felt a bit tired.  THe next morning at work about 10am, she started feeling a bit nauseous.  She went home and about noon started throwing up.  SHe took her temp that afternoon about 1pm and it was 102.  She also states feeling week, having chills and body aches.   ALso states that she tried taking ibuprofen and could not keep anything down.  She went to bed and states she started feeling better that evening and felt much better the next day.  As of today, Friday, october 30, pt feels back to normal.
administered an expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 34-year-old male patient who received HAV (Havrix) (batch number X9A9B, expiry date 14th June 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 1st September 2022, the patient received Havrix and Havrix Pre-Filled Syringe Device. On 1st September 2022, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 01-Sept 2022 Reporter's comment: The clinical supervisor reported that nurse administered an expired dose of Havrix to an adult patient. The reporter consented to follow-up. Additional supportive information: The patient received an expired dose of Havrix, which led to expired  vaccine used.
Tested positive for COVID 4/15; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Tested positive for COVID 4/15) in a 46-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. GJ6742) for COVID-19 prophylaxis.     Prior to vaccination patient was not diagnosed with COVID-19.  Concurrent medical conditions included Drug allergy (Name of Drug Reported as: No).    On 11-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 15-Apr-2023, the patient experienced COVID-19 (Tested positive for COVID 4/15). At the time of the report, COVID-19 (Tested positive for COVID 4/15) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2023, SARS-CoV-2 test: Positive.         Date of birth of patient reported.  No concomitant medications were reported.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and also not received any other medications within 2 weeks of vaccination.  Patient did not receive any treatment medications.
A week after my first vaccine I started developing hives all over of my body. I would get them about 2-3 times a week.; This is a spontaneous report from a contactable consumer or other non hcp.   A 27-years-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot Number: EL9266 expiry date was not reported) as dose 1 via an unspecified route of administration, administered at Arm Left on 13Feb2021 as a single dose (age at avccination was 27-years-old) for COVID-19 immunisation. Patient's medical history reported as none. The patient's concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have known allergies. The patient no other vaccine in four weeks. The patient had not received other medications in two weeks. The patient experienced a week after first vaccine she started developing hives all over of patient body and she would get them about 2-3 times a week. She went to an allergist and she cannot diagnose (urticaria) (disability). Therapeutic measures were taken because of a week after my first vaccine she started developing hives all over of my body. Patient received treatment of Allegra twice a day and Zyrtec. She would get them about 2-3 times a week. The outcome event was not recovered.   Information is needed. Further inform is requested.
Information has been received from a healthcare professional concerning a patient (age and gender not specified) who was scheduled to be vaccinated with a dose of pneumococcal 23v polysaccharide vaccine, however, due to nursing error, the patient was administered PREVNAR. There were no symptoms noted. Additional information has been requested.
This spontaneous report as received from registered nurse refers to a patient of unknown age and gender. Patient's concurrent conditions and relevant medical history was not reported. Approximately on an unknown date in 2011 (reported as three years ago), patient was vaccinated with first dose of GARDASIL (0.5 ml) (lot number unknown), intramuscular. On 23-SEP-2014 the patient was vaccinated with second dose of GARDASIL (0.5 ml) (lot number unknown), intramuscularly. Concomitant medications were not reported. No adverse events were reported. The outcome of the events was unknown. The causality of the events with GARDASIL was not reported. Additional information has been requested.
None. Patient filled out form to say that he had not received any Covid vaccines. Patient was given full dose of Moderna. When we submitted data to VIIS, we found out that he actually had a J&J vaccine on 03/06/2021
Nausea, vomiting, Temp over 100, extremely weak, head ache
blisters; covid arm; itched; red oval rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE VESICLES (blisters), VACCINATION SITE REACTION (covid arm), VACCINATION SITE PRURITUS (itched) and VACCINATION SITE RASH (red oval rash) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (sulfa), Drug allergy (demerol) and Allergy to chemicals (used in eye drops).    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE VESICLES (blisters), VACCINATION SITE REACTION (covid arm), VACCINATION SITE PRURITUS (itched) and VACCINATION SITE RASH (red oval rash). At the time of the report, VACCINATION SITE VESICLES (blisters), VACCINATION SITE REACTION (covid arm), VACCINATION SITE PRURITUS (itched) and VACCINATION SITE RASH (red oval rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment :Her HCP treated her rash.   This case was linked to US-MODERNATX, INC.-MOD-2021-064087 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-064087:2nd dose
24-30 hours of flu-like symptoms: flushed, slightly elevated temperature, chills.
fever, chills, nausea, fatigue, body ache, swelling/lump at injection site - aches began day of vaccine, fever, chills, nausea and swelling at injection site began the following morning and lasted until morning of 04/21/2021
Area to LD where Tdap given was reported to be red and "a little puffy".  Redness was reported by Father to be 3 1/2 to 4" oval area to site that was also sore.  Mom took child to MD on 5/13 for assessment.
Diarrhea; headache; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose bnt162b2 (Pfizer-Biontech covid-19 vaccine), via an unspecified route of administration on 18Jan2021 in the afternoon at SINGLE DOSE for covid-19 immunisation. Medical history included Pulmonary fibrosis, lung infection. Concomitant medication included azithromycin (AZITHROMYCIN) on Mondays, Wednesdays and Fridays to Preventative for lung infection due to Pulmonary fibrosis, ibuprofen (IBUPROFEN) for Pulmonary fibrosis and other problems, had not taken any Ibuprofen since 16Jan2021. The patient had not had any symptoms other than a headache, so she is not sure if this was because of the vaccine or not; diarrhea on 20Jan2021. This consumer wanted to know how long before and after should get the Pfizer COVID-19 Vaccine shot do you have to stop taking Ibuprofen. She has Pulmonary fibrosis and other problems that she takes Ibuprofen for. She got the first dose of Pfizer COVID-19 Vaccine 18Jan2021. They did not tell her she would be getting the Pfizer COVID-19 Vaccine until the night before: 17Jan2021. She has not taken any Ibuprofen since Saturday night: 16Jan2021. She also mentioned that she had Diarrhea for 2 days in a row on Wednesday 20Jan2021 and Thursday 21Jan2021; Diarrhea is not too unusual for her because she takes Azithromycin 1 tablet 3 days/week continuously as preventative for lung infection due to her pulmonary fibrosis; she usually will get diarrhea on the day she takes the Azithromycin, but not on the days she does not-so the 2 days in a row of diarrhea she had 20Jan2021- 21Jan2021 she wanted to know if could be a possible side effect of the Pfizer COVID-19 Vaccine. The event outcome was unknown.
This case was reported by a other health professional via sales rep and described the occurrence of pain in arm in a 17-year-old female patient who received BEXSERO (batch number 16B501, expiry date unknown). On an unknown date, the patient received the 1st dose of BEXSERO .5 ml. On an unknown date, unknown after receiving BEXSERO, the patient experienced pain in arm. The patient was treated with ibuprofen. On an unknown date, the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to BEXSERO. Additional details were provided as follows: The case was received from a Medical assistant. The age at the vaccination was not reported. The patient experienced pain, hurt to move arm for three weeks that was painful not red or swollen. The patient was treated with ibuprofen for several days.
Muscle pain; headache she couldn't move; aches; sick; chills; very tired, she cant do anything; sweat; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), PAIN IN EXTREMITY (aches), HYPERHIDROSIS (sweat), ASTHENIA (sick) and FATIGUE (very tired, she cant do anything) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced PAIN (body aches), HYPERHIDROSIS (sweat), FATIGUE (very tired, she cant do anything) and PYREXIA (fever). On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (aches), ASTHENIA (sick), HEADACHE (headache she couldn't move) and CHILLS (chills). On 24-Feb-2021, the patient experienced MYALGIA (Muscle pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (body aches), PAIN IN EXTREMITY (aches), HYPERHIDROSIS (sweat), ASTHENIA (sick), FATIGUE (very tired, she cant do anything), HEADACHE (headache she couldn't move), MYALGIA (Muscle pain), PYREXIA (fever) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.8 (High) 101.8°F.         Concomitant medication included Thyroids pills, slow dose, The patient reported that she had pretty good immune system.
Neuroparalytic syndrome characterized by weakness of the arm with assoc. nausea & emesis
tested + for covid 2-8-2022,  deceased 12-9-22,  was a resident of local healthcare facility
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Patient's medical history was not reported. On 24-JUN-2014 the patient was inadvertently vaccinated with VAQTA (strength, dose number, lot# and expiry date unknown) 1 ml, intramuscularly for vaccine prophylaxis that had been improperly stored. No concomitant medications were administered. No adverse effect was reported. The outcome of patient was inadvertently administered VAQTA on 24-JUN-2014 that had been improperly stored and no adverse effect was unknown. No further information provided. Additional information has been requested.
Had the shot Wed. Thursday he came home in tears w stomach pain, nausea, vomiting. He had been on a field trip that day so I didn't put two and two together. I administered PEPTO and ADVIL Friday he woke up w chills, sore throat and slightly nausea. Came home Friday w the mark on his arm, but it was light. By 7 pm Friday night it was huge and red and swollen. Went to ER last night and they confirmed it was a vax reaction and/or infection from needle. Steroid cream and oral antibiotic.
Less than 24 hours after receiving 3rd Pfizer Covid booster vaccine, there was significant swelling on my eyelids, and lips with redness. It progressively worsened and I went to the ER on 9 December 2021. I still had the facial swelling, a rash developed in splotches in my face, neck, around my lips. My face was sensitive/painful to touch, it was peeling in the affected areas. During this time I had been taking antihistamines. For treatment, I was given a steroid injection, prescription for high dose oral steroids x5days, mupirocin topical ointment x14 days for my lips which were cracked/peeling and this point, and vanicream ointment for the other affected areas. I had a consult with dermatology on 11 Jan 2021 and I was told it was a systemic reaction that could take 4 to 6 weeks to recover, and I am in the recovery mode still and not recovered.
pt recvd vax; 2 hrs after vax, pt woke up crying from nap;very fretful x 24 hrs; fever of 102; to er; saw MD, told not to take pertussis anymore; tx apap only;
DEHYDRATED; INJECTION SITE REACTION LIKE BUMP/ HEAT; FEVER; HEADACHE; FATIGUE; INJECTION SITE REDNESS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced dehydrated, injection site reaction like bump/ heat, fever, headache, fatigue, and injection site redness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dehydrated, injection site reaction like bump/ heat, fever, fatigue, and injection site redness, and the outcome of headache was not reported. This report was non-serious.
approx MAY92 recvd Engerix-B & approx 8 wks following dose pt started experiencing GBS & is still experiencing sx; seen by MD; hospitalized in ICU;
Employee was vaccinated with both doses of the Pfizer vaccine on 12/17/2020 and 1/5/2021.  He tested positive for Covid-19 on 2/2/2021.